Want to see HK:1246 full AI Analyst Report?
Top Page
Rating:―N/A
Price Target:―
Action:N/A
Date:―
No summary available
Positive Factors
Healthcare Sector Focus
Boill Healthcare Holdings' focus on healthcare services and property development positions it in a growing industry with long-term demand, providing potential for sustainable revenue streams.
Negative Factors
High Leverage
High leverage and negative equity position present significant financial risk, potentially limiting the company's ability to invest in growth opportunities and increasing vulnerability to economic downturns.
Read all positive and negative factors
Positive Factors
Negative Factors
Healthcare Sector Focus
Boill Healthcare Holdings' focus on healthcare services and property development positions it in a growing industry with long-term demand, providing potential for sustainable revenue streams.
Read all positive factors
Boill Healthcare Holdings Limited (1246) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$28.52M
Dividend YieldN/A
Average Volume (3M)0.00
Price to Earnings (P/E)―
Beta (1Y)N/A
Revenue Growth234.82%
EPS Growth76.60%
CountryHK
Employees26
SectorReal Estate
Sector Strength53
IndustryReal Estate - Development
Share Statistics
EPS (TTM)-0.09
Shares Outstanding1,358,000,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)-1.31
Price to Sales (P/S)1.52
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Boill Healthcare Holdings Limited Business Overview & Revenue Model
Company Description
Boill Healthcare Holdings Limited functions as an investment holding company, primarily engaged in foundation piling contracts within Hong Kong and mainland China. Its operations are diversified across four main segments: Property Development, Hea...
How the Company Makes Money
Boill Healthcare Holdings Limited generates revenue through two main streams: healthcare services and property development. In the healthcare sector, the company earns income by operating healthcare facilities, which may include hospitals, clinics...
Boill Healthcare Holdings Limited Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 285.20M | 348.27M | 1.00B | 216.71M | 106.35M |
| Gross Profit | 10.52M | -810.00K | 106.85M | 18.97M | 10.79M |
| EBITDA | -36.80M | -180.22M | 48.36M | -37.34M | -109.29M |
| Net Income | -118.64M | -428.25M | -517.80M | -142.49M | -189.43M |
Balance Sheet | |||||
| Total Assets | 1.30B | 2.42B | 3.49B | 3.77B | 2.18B |
| Cash, Cash Equivalents and Short-Term Investments | 1.08M | 79.06M | 93.55M | 151.72M | 98.91M |
| Total Debt | 842.17M | 1.17B | 1.57B | 825.70M | 961.94M |
| Total Liabilities | 1.63B | 2.41B | 3.24B | 2.82B | 1.29B |
| Stockholders Equity | -332.84M | -135.58M | -11.54M | 465.62M | 407.21M |
Cash Flow | |||||
| Free Cash Flow | 0.00 | 29.75M | -128.39M | -232.34M | -36.96M |
| Operating Cash Flow | 0.00 | 29.75M | -128.34M | -232.15M | -31.82M |
| Investing Cash Flow | 0.00 | 408.46M | -575.82M | 50.16M | -17.13M |
| Financing Cash Flow | 0.00 | -452.39M | 645.67M | 230.92M | 79.33M |
Boill Healthcare Holdings Limited Technical Analysis
Negative
0.02
Price Trends
0.02
Negative
0.02
Negative
0.02
Negative
Market Momentum
>-0.01
Neutral
100.00
Negative
0.00
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1246, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of >-0.01 indicates Neutral momentum. The RSI at 100.00 is Negative, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1246.
Boill Healthcare Holdings Limited Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
| ― | HK$28.52M | -0.24 | 50.66% | ― | 234.82% | 76.60% | |
46 Neutral | HK$144.65M | -0.16 | 5.53% | ― | 212.45% | 75.88% | |
41 Neutral | HK$28.06M | >-0.01 | 35.43% | 1.99% | -60.47% | 26.66% | |
40 Underperform | HK$24.62M | >-0.01 | 221.31% | 12.38% | ― | ― |
* Real Estate Sector Average
HK:1246
Boill Healthcare Holdings Limited
0.02
0.00
0.00%
HK:1107
Modern Land (China) Co., Ltd.
0.01
>-0.01
-38.10%
HK:1862
Jingrui Holdings Ltd.
0.02
<0.01
23.08%
HK:2608
Sunshine 100 China Holdings Ltd.
0.01
<0.01
10.00%
HK:2699
Xinming China Holdings Limited
5.60
-48.30
-89.62%
HK:6611
Sanxun Holdings Group Limited
0.05
0.00
0.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―